BIT225, a Novel Inhibitor of HIV-1 Release from HIV-1 Reservoirs of - PDF document

Nov 06, 2022 •156 likes •302 views

BIT225, a Novel Inhibitor of HIV-1 Release from HIV-1 Reservoirs of the Myeloid Lineage John Wilkinson* 1 , Carolyn Luscombe 1 , Gary Ewart 1 , Stephen Kerr 2 , Nattaya Tanliang 3 , Winai Ratanasuwan 3 , Robert Murphy 4 , and Michelle Miller 1 1

Recommend

AGM 16 October 2009 Key Highlights for 2008/2009 Successful completion of Phase I/IIa

ASX:BIT AGM 16 October 2009 Key Highlights for 2008/2009 Successful completion of Phase I/IIa clinical trial (BIT225-003) of BIT225 in Hep C+ subjects Successful rights issue, raising $0.8 million in March 09 1 BIT225-003:

276 views • 14 slides

BI 201335, a NS3/4A Serine Protease Inhibitor, and BI 207127, a NNI NS5b Polymerase Inhibitor for

BI 201335, a NS3/4A Serine Protease Inhibitor, and BI 207127, a NNI NS5b Polymerase Inhibitor for treatment of chronic HCV infection Wulf Otto Bcher Boehringer Ingelheim Pharma, Biberach, Germany NS3/4A Protease Inhibitor BI 201335 Chemical

629 views • 15 slides

Novel Gaits for a Novel Novel Gaits for a Novel Crawling/Grasping Mechanism Crawling/Grasping

Novel Gaits for a Novel Novel Gaits for a Novel Crawling/Grasping Mechanism Crawling/Grasping Mechanism Richard Voyles Department of Computer Science and Engineering University of Minnesota AMAM 2000 University of Minnesota Department of

293 views • 27 slides

HPPD-inhibitor resistance stewardship: The perspective of the HRAC HPPD- inhibitor Working Group

2014 WSSA Vancouver, British Columbia HPPD-inhibitor resistance stewardship: The perspective of the HRAC HPPD- inhibitor Working Group Gordon D. Vail 1 , Roland S. Beffa 2 , William L. Patzoldt 3 , Peter J. Porpiglia 4 and Walter E. Thomas 5

544 views • 16 slides

PhenX Measures: Inhibitors Barbara Konkle and Diane Nugent 4.18 Inhibitors Assays

PhenX Measures: Inhibitors Barbara Konkle and Diane Nugent 4.18 Inhibitors Assays Existing Inhibitor State Evolving Inhibitor State Resolving or Persistent Inhibitor State Laboratory Measures of Inhibitor Impact Factor VIII

275 views • 12 slides

GP IIB/IIIA Inhibitor Use During GP IIB/IIIA Inhibitor Use During Endovascular Intervention

GP IIB/IIIA Inhibitor Use During GP IIB/IIIA Inhibitor Use During Endovascular Intervention Endovascular Intervention Jay S. Yadav M.D. Director, Vascular Intervention Dept of Cardiovascular Medicine The Cleveland Clinic Foundation Name: Jay

1.03k views • 44 slides

efits of the I inhibitor ivabradine be f inhibitor ivabradine f Y artery d in patients with

S tudy assess I n G the morbidity-mortality S tudy assess I n G the morbidity-mortality N efits of the I be N efits of the I inhibitor ivabradine be f inhibitor ivabradine f Y artery d in patients with coronar Y artery disease isease in

695 views • 20 slides

Release Reporting RELEASE NOTI FI CATI ON RELEASE NOTI FI CATI ON RELEASE NOTI FI CATI ON

Release Reporting RELEASE NOTI FI CATI ON RELEASE NOTI FI CATI ON RELEASE NOTI FI CATI ON RELEASE NOTI FI CATI ON REQUI REMENTS TABLE REQUI REMENTS TABLE REQUI REMENTS I N REQUI REMENTS I N 11/ 10/ 2011 11/ 10/ 2011 MI CHI GAN MI CHI GAN

104 views • 7 slides

HIV tropism assessment HIV tropism assessment HIV tropism assessment HIV tropism assessment

HIV tropism assessment HIV tropism assessment HIV tropism assessment HIV tropism assessment using next generation sequencing using next generation sequencing using next generation sequencing using next generation sequencing Mattia CF Prosperi

783 views • 23 slides

HIV- -1 Integrase: 1 Integrase: HIV not just an not just an other HIV enzyme other HIV

HIV- -1 Integrase: 1 Integrase: HIV not just an not just an other HIV enzyme other HIV enzyme Vandekerckhove Linos MD, PhD Dpt. of Infectious Diseases University Hospital Ghent Belgium IN a 32kD enzyme IN a 32kD enzyme 288 1

444 views • 22 slides

Release management in Debian - Can we do better? Frans Pop FOSDEM 2009, Brussels Frans Pop

Release Management Stable release Management The etch-and-a-half release The Lenny release Release management in Debian - Can we do better? Frans Pop FOSDEM 2009, Brussels Frans Pop Release management in Debian - Can we do better? Release

194 views • 18 slides

HIV mother-to-child HIV identified in 1983 transmission of HIV AIDS syndrome described

Prevention of HIV mother-to-child HIV identified in 1983 transmission of HIV AIDS syndrome described in 1981 Kaposis sarcoma, Pneumocystis jiroveci pnemumonia and wasting often combined Retrospectively, cases of HIV seen

526 views • 8 slides

COR388, A NOVEL GINGIPAIN INHIBITOR, DECREASES FRAGMENTATION OF APOE IN ALZHEIMERS DISEASE

COR388, A NOVEL GINGIPAIN INHIBITOR, DECREASES FRAGMENTATION OF APOE IN ALZHEIMERS DISEASE CENTRAL NERVOUS SYSTEM Disclaimer Certain information contained in this presentation and statements made orally during this presentation relate to or

218 views • 20 slides

AT-007, a Novel CNS Penetrant Aldose Reductase Inhibitor Prevents the Metabolic and Tissue

AT-007, a Novel CNS Penetrant Aldose Reductase Inhibitor Prevents the Metabolic and Tissue Specific Abnormalities of Galactosemia in a GALT Deficient Rat Model of Disease Riccardo Perfetti, MD, PhD Chief Medical Officer, Applied Therapeutics

312 views • 13 slides

Intravenous SNF472 (a novel inhibitor of vascular calcification) does not affect bone histology

Intravenous SNF472 (a novel inhibitor of vascular calcification) does not affect bone histology and histomorphometry in healthy and uremic animal models MD Ferrer 1 , C Salcedo 1 , AZ Canals 1 , M Lazo 2 , JM Campistol 2,3 , J Perell 1,4 1

248 views • 20 slides

A First-in-class Phase 1 Dose-escalation Study of the Novel Oral ERK 1/2 Kinase Inhibitor BVD-523

A First-in-class Phase 1 Dose-escalation Study of the Novel Oral ERK 1/2 Kinase Inhibitor BVD-523 (ulixertinib) in Patients with Advanced Solid Tumors Jeffrey R. Infante, Filip Janku, Anthony W. Tolcher, Manish Patel, Ryan J. Sullivan, Keith T.

227 views • 21 slides

Awa wareness reness - A HIV V Cas ase NRP EEEjr01A Leung Fee Ming Shannon & Toh Yee

Ga Gami mifi fica catio tion n for Cultiv ltivating ating Soci cial al Awa wareness reness - A HIV V Cas ase NRP EEEjr01A Leung Fee Ming Shannon & Toh Yee Shuen, Kaela Presentation Outline 1. Introduction a. Gamification b.

635 views • 24 slides

WHO Update Irena Prat and Jose Hansen World Health Organization Vancouver, 14-16 March 2017

WHO Update Irena Prat and Jose Hansen World Health Organization Vancouver, 14-16 March 2017 What's new ? Prequalification of IVDs New guidance documents Post-market surveillance Inspections Regulatory strengthening 2

364 views • 13 slides

Donor Characterisation and Identification of Infection Transmission Risks (Beyond S. aureus )

Donor Characterisation and Identification of Infection Transmission Risks (Beyond S. aureus ) Ins.Ushiro-Lumb@nhsbt.nhs.uk Lead Clinical Microbiologist for Organ Donation and Transplantation Take home messages: To reflect on Rationale

908 views • 25 slides

Cultural Competence & Field Instruction: working with US-Mexico transnational populations in

Cultural Competence & Field Instruction: working with US-Mexico transnational populations in Southern California: Substance Use and increased risk for poor health outcomes, specifically HIV. Mara Luisa Ziga, Ph.D. Associate Professor

1.06k views • 44 slides

Heather Lorenz, MSOH, CIH, CSP, CMLSO Director, EHRS Environmental Health and Radiation Safety

Heather Lorenz, MSOH, CIH, CSP, CMLSO Director, EHRS Environmental Health and Radiation Safety Department Health Science Campus, Main Campus, Scott Park, Lake Erie Center and the UT Medical Center and associated clinics. Responsible

1.06k views • 48 slides

Dynamics of the HIV Treatment Cascade in the United States To download today s presentation

PHSSR Research-In-Progress Series: Quality, Cost and Value of Public Health Services Wednesday, June 3, 2015 12:00 - 1:00 pm ET Go With the Flow: Understanding the Temporal Dynamics of the HIV Treatment Cascade in the United States To

481 views • 22 slides

2/4/14 Debate: Haploidentical (haplo) versus Umbilical Cord Blood (UCB) Transplant Ephraim

2/4/14 Debate: Haploidentical (haplo) versus Umbilical Cord Blood (UCB) Transplant Ephraim Joseph Fuchs, MD, MBA Professor of Oncology and Immunology Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, MD Objectives

357 views • 9 slides

Strategies to improve long-term outcomes after kidney transplantation Miha Arnol 5 th Congres of

Strategies to improve long-term outcomes after kidney transplantation Miha Arnol 5 th Congres of Nephrology in BIH, Tuzla, October 18, 2019 Kidney transplant medicine A story of success A story of barriers A story of how modern

692 views • 54 slides